Another Genentech? These are the most likely companies
San Francisco Business Times took a look at the Bay Area’s life sciences industry and found that Genentech is still the gold standard. However, these nine companies do stand out as having the potential to become the next Genentech:
1. BioMarin Pharmaceutical
2. Calico Life Sciences LLC
3. Gilead Sciences Inc.
4. NGM Biopharmaceuticals Inc.
5. OncoMed Pharmaceuticals Inc.
6. Ultragenyx Pharmaceuticals Inc.
7. Verily Life Sciences
8. Audentes Therapeutics
9. Denali Therapeutics
